Novel research has indicated a distinct group of circulating tumor cells that are associated with breast cancer brain metastases, the findings may help detect the tumors while they are still treatable.
Browsing: brain tumor
Researchers have uncovered the role of cellular prion protein (PrPC) in Neurofibromatosis Type 2 (NF2) related tumors, offering hope to neuro-tumor patients.
Possible damage to immune-privileged sites in natural killer cell therapy in cancer patients: side effects of natural killer cell therapy
Find out in this perspective article how cytotoxic and expanded NK cells induced in cancer patients may be turned into pathogenic factors if they enter immune-privileged microenvironments in susceptible individuals.
New research from the University of Edinburgh highlights how an olive oil component, oleic acid, inhibits cancer-causing proteins in the brain.
This review reports the results of application of short peptides in glioma therapy clinical trials, their rises and falls.
Does Graded Prognostic Assessment outperform Recursive Partitioning Analysis in patients with moderate prognosis brain metastases?
Primary research to evaluate whether Recursive Partitioning Analysis or Graded Prognostic Assessment is more useful to clinicians.
A team of investigators on the Head Start III trial have highlighted that patients with reduced radiotherapy experience a worse prognosis following deviations from the treatment protocol.
Curative intent therapy in oligometastatic lung cancer with an unresectable primary with N3 nodes: case report and review of the literature
In this case report the authors present systematic therapy as a multimodality tool in the management of patients with oligometastatic disease.
Outcomes and toxicity of stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab
In this research article the authors review the efficacy and safety of radiosurgery for melanoma brain metastases in patients treated with ipilimumab .
Better outcomes observed with targeted radiosurgery versus whole-brain radiation in metastatic brain tumors
Study demonstrates better outcomes with stereotactic radiosurgery compared with whole-brain radiation therapy in postsurgical metastatic brain tumors.